Last edition
News about Global Pharma
Schneider Electric Introduces EcoStruxure for Life Science Segment
Schneider Electric has released EcoStruxure, a next-generation software technology, for its Life Sciences Segment.
Global Pharma | 10/06/2024 | By Aishwarya | 1156
Lupin Acquires Two Brands from Sanofi in Europe and Canada
Lupin has announced that its European hub entity, Lupin Atlantis Holdings SA, has completed the acquisition of two well-known brands, Aarane in Germany and Nalcrom in Canada and the Netherlands, along with the associated trademark rights, from Sanofi.
Global Pharma | 10/06/2024 | By Aishwarya | 1565
Cycle Pharmaceuticals Offers All-Cash Proposal to Acquire Vanda Pharmaceuticals
Cycle Pharmaceuticals Ltd. has confirmed that it proposed to the Board of Directors of Vanda Pharmaceuticals, Inc. to acquire 100 percent of Vanda’s issued and outstanding shares for a cash consideration of USD 8.00 per Vanda share.
Global Pharma | 07/06/2024 | By Aishwarya | 936
CordenPharma Announces Partnership with Certest
CordenPharma has signed a collaboration agreement with Certest, a Spanish company focused on the development of new products with special emphasis in Drug Delivery with LNPs and API synthesis.
Global Pharma | 07/06/2024 | By Aishwarya | 449
Aterian Investment Partners Acquires Contract Pharmaceuticals
Aterian Investment Partners has announced the acquisition of Contract Pharmaceuticals Ltd. Canada, a leading North American contract development and manufacturing organization (CDMO) of non-sterile liquid and semi-solid dosage forms.
Global Pharma | 07/06/2024 | By Aishwarya | 314
Nucleus RadioPharma Receives Series A Extension Funding from AstraZeneca
Nucleus RadioPharma has closed its Series A extension round with new investor AstraZeneca.
Global Pharma | 06/06/2024 | By Aishwarya | 822
AstraZeneca Completes Acquisition of Fusion
AstraZeneca has completed the acquisition of Fusion Pharmaceuticals Inc., a clinical-stage biopharmaceutical company developing next-generation radioconjugates (RCs).
Global Pharma | 06/06/2024 | By Aishwarya | 705
The result of nearly a decade of research, the late breaking research and ongoing scientific trials mark a breakthrough in antioxidant technology to prevent premature aging. When the skin is exposed to ultraviolet rays, Cyclobutane Pyrimidine Dimers [CPDs] are formed, also known as thymine dimers in the DNA molecule.
Global Pharma | 05/06/2024 | By Manvi | 837
Moon Surgical Gets Second FDA Clearance, Covering its Commercial Maestro Robotic Surgery System
Moon Surgical announced the United States Food and Drug Administration (FDA) clearance for the commercial version of its unique Maestro surgical system.
Global Pharma | 05/06/2024 | By Manvi | 590
Kindeva Expands UK Facilities at Charnwood Campus
Kindeva Drug Delivery has expanded their Loughborough, UK, facilities at the Charnwood Campus Science Innovation and Technology Park.
Global Pharma | 05/06/2024 | By Aishwarya | 707
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy